GlassScriptPhysician profile
Meredith H Mcdaniel
NPI 1871064113
$16,794.38
in general payments reported to CMS, 2019-2025
35 companies · $2,560 in 2025
The $2,560 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,334 · 2022: $2,437 · 2023: $2,705 · 2024: $3,758 · 2025: $2,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,015 · Travel and Lodging: $7.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,015.33 |
| Travel and Lodging | $7.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,215.29 | 2021-2025 | Aveir, Jot Dx, Ensite |
| Boston Scientific Corporation | $1,343.27 | 2021-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $873.96 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $722.50 | 2021-2024 | Xarelto |
| Medtronic, INC. | $634.62 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Philips North America LLC | $622.53 | 2022-2025 | (Ck4) Mcot, Ecc Solutions |
| Abiomed | $549.44 | 2022-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $546.23 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.41 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $388.69 | 2022-2025 | Camzyos, Eliquis |
| Atricure, INC. | $337.94 | 2022-2023 | |
| Biosense Webster, INC. | $336.50 | 2022-2024 | Carto 3, Nuvision Ice Catheter |
| Lexicon Pharmaceuticals, INC. | $308.27 | 2023-2024 | Inpefa |
| Shockwave Medical, INC | $276.68 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $243.85 | 2021-2025 | Ozempic, Wegovy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $231.20 | 2025 | Assure Wcd |
| Pfizer INC. | $210.95 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $189.61 | 2023-2025 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $185.77 | 2022-2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $179.54 | 2022-2025 | Amvuttra |
| Inari Medical, INC. | $144.95 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $125.33 | 2023 | Uptravi, Opsumit |
| Amgen INC. | $125.24 | 2022-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $103.33 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals International, Plc | $88.96 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $87.93 | 2024-2025 | |
| Daiichi Sankyo INC. | $69.87 | 2021-2024 | Injectafer |
| Azurity Pharmaceuticals, INC. | $59.91 | 2023-2024 | Edarbi, Edarbyclor |
| Cardiva Medical, INC. | $51.85 | 2024 | Savvywire |
| Sanofi-Aventis U.S. LLC | $36.10 | 2024 | |
| Heartflow, INC. | $35.35 | 2025 | |
| Bridgebio Pharma, INC. | $25.56 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $18.49 | 2023 | Evkeeza |
| Glaxosmithkline, LLC. | $17.30 | 2025 | Shingrix |
| Alexion Pharmaceuticals, INC. | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.